Observational studyAbdominal radiology (New York)2026
Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Observational study in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the association between preoperative computed tomography (CT)-measured sarcopenia and short-term postoperative outcomes in patients with peritoneal carcinomatosis (PC) undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). In addition, specific objectives included determining the prevalence of sarcopenia, evaluating the association of postoperative prognosis and outcomes, and assessing the prevalence of postoperative complications in this population undergoing CRS-HIPEC. MATERIALS AND
methodsRetrospective observational study included patients with PC undergoing CRS + HIPEC at a specialized center. Sarcopenia was assessed on preoperative CT using the skeletal muscle index (SMI) at the L3 level. Postoperative outcomes and survival were analyzed using standard univariable and multivariable statistical methods.
resultsNo significant differences in short-term postoperative outcomes were observed between sarcopenic and non-sarcopenic patients. Overall survival did not differ significantly between groups. However, sarcopenia was independently associated with shorter disease-free survival (DFS) and a higher risk of recurrence.
conclusionSarcopenia was independently associated with shorter DFS and a higher risk of recurrence, supporting its role as a prognostic marker rather than a driver of perioperative morbidity. Preoperative identification may improve risk stratification and guide long-term follow-up, while prospective studies are needed to determine whether targeted interventions can improve outcomes.
Indexed as
Identifiers
41910742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.